InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score54
United States Fiscal year ends December CIK 0001658247 Results filed 3 Aug 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
4,995
$20.02
$100.00K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
6,542
$15.29
$100.03K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
4,422
$22.61
$99.98K
Richard Scott Struthers
7 Aug 2026
President & CEO
Exercised, kept
3,969
$25.19
$99.98K
Coelho Rogerio Vivaldi
2 Jul 2026
Director
Sold on a plan
3,000
$40.00
$120.00K
Stephanie Okey
17 Jun 2026
Director
Sold on a plan
608
$36.22
$22.02K
Stephanie Okey
17 Jun 2026
Director
Sold on a plan
6,292
$35.62
$224.12K
Jeff E. Knight
8 Apr 2026
Chief Dev. & Operating Officer
Sold after exercise
85,163
$40.10
$3.42M
Richard Scott Struthers
16 Mar 2026
President & CEO
Sold on a plan
8,785
$37.77
$331.81K
Richard Scott Struthers
16 Mar 2026
President & CEO
Sold on a plan
13,196
$37.11
$489.70K
Stephen F. Betz
16 Mar 2026
Chief Scientific Officer
Sold on a plan
4,241
$37.77
$160.18K
Stephen F. Betz
16 Mar 2026
Chief Scientific Officer
Sold on a plan
6,371
$37.11
$236.43K
Jeff E. Knight
16 Mar 2026
Chief Operating Officer
Sold on a plan
3,961
$37.77
$149.61K
Jeff E. Knight
16 Mar 2026
Chief Operating Officer
Sold on a plan
5,950
$37.11
$220.80K
Coelho Rogerio Vivaldi
12 Mar 2026
Director
Sold on a plan
523
$36.77
$19.23K
Coelho Rogerio Vivaldi
12 Mar 2026
Director
Sold on a plan
4,477
$36.08
$161.53K
Tobin Schilke
3 Mar 2026
Chief Financial Officer
Sold on a plan
6,713
$39.67
$266.30K
Stephanie Okey
3 Mar 2026
Director
Sold on a plan
3,000
$39.67
$119.01K
Isabel Kalofonos
5 Jan 2026
Chief Commercial Officer
Sold after exercise
2,500
$55.00
$137.50K
Stephen F. Betz
26 Dec 2025
Chief Scientific Officer
Exercised, kept
18,000
$1.91
$34.38K
Richard Scott Struthers
18 Dec 2025
President & CEO
Exercised, kept
28,400
$15.29
$434.24K
Richard Scott Struthers
18 Dec 2025
President & CEO
Exercised, kept
16,342
$9.28
$151.65K
Dana Pizzuti
1 Dec 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$45.02
$225.10K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 3
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 4,245,150
History held since 20 Jul 2018